Kowalec, Kaarina http://orcid.org/0000-0003-3928-9879
Lu, Yi http://orcid.org/0000-0001-9933-3654
Song, Jie http://orcid.org/0000-0002-7357-2136
Dalman, Christina
Hultman, Christina M.
Larsson, Henrik
Lichtenstein, Paul http://orcid.org/0000-0003-3037-5287
Sullivan, Patrick F.
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (793530)
Gouvernement du Canada | Canadian Institutes of Health Research (Banting Program)
Vetenskapsrådet (D0886501)
Article History
Received: 23 December 2020
Revised: 8 January 2021
Accepted: 15 January 2021
First Online: 15 March 2021
Conflict of interest
: P.F.S. reports the following potentially competing financial interests. Current: Lundbeck (advisory committee, grant recipient). Past 3 years: Pfizer (scientific advisory board), Element Genomics (consultation fee) and Roche (speaker reimbursement). H.L. has served as a speaker for Evolan Pharma and Shire and has received research grants from Shire; all outside the submitted work. Drs. Kowalec, Lu, Song, Dalman, Hultman and Lichtenstein report no financial relationships with commercial interests.